Procter & Gamble Co said on Thursday it has signed an agreement to acquire the consumer health business of German pharmaceuticals company Merck KGaA for about $4.21 billion (3.4 billion euros).
The acquisition enables P&G to add to its portfolio of existing consumer healthcare capabilities and brands such as Vicks, Metamucil, Pepto-Bismol, Crest and Oral-B.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)